Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Aug;64(2):373–376. doi: 10.1038/bjc.1991.310

Inter-clinician agreement on the recognition of clinical pigmentary characteristics of patients with cutaneous malignant melanoma. Studies of melanocytic nevi, VI.

G C Roush 1, R L Barnhill 1, M S Ernstoff 1, J M Kirkwood 1
PMCID: PMC1977520  PMID: 1892767

Abstract

The number and type of melanocytic nevi are among the most important known predictors of risk for cutaneous malignant melanoma. In this study, examinations of the skin were conducted by two to four clinicians on 153 patients with newly diagnosed melanoma, and the agreement among clinicians was quantified regarding number of nevi and freckling. The index of agreement (calculated as the intra-class correlation coefficient) was 59.7% and 69.0% for freckling on the right forearm and on the shoulders, respectively; agreement was above 50% for only one of six pairs of clinicians in examining freckling on the right forearm, while agreement was above 50% for four of the six pairs of clinicians in examination of freckling on the shoulder. For palpable nevi of the arms (used in at least two case-control studies as a predictor of risk), the agreement was 36.1% when computed for three examiners assessing 81 patients. However, for total arm nevi (both palpable and non-palpable), assessed on a subset of 48 patients, the agreement was 88.2%; this and other analyses indicated that the difficulty in achieving a consensus for palpable nevi lay in whether or not lesions were considered to be 'palpable' or 'non-palpable'. Agreement for total number of atypical nevi on the body and total number of all types of nevi were 87.4% and 91.8% respectively. These data suggest that the kinds of lesions on which agreement might be reached are total atypical nevi and total nevi of all types on the arms and on the entire body. Greater difficulty might be found in achieving consistency among investigators and among clinicians in examining individual patients with respect to freckling on the arms and 'palpable' nevi. However, some consistency was achieved even with these latter two clinical features.

Full text

PDF
373

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnhill R. L., Roush G. C., Duray P. H. Correlation of histologic architectural and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi. Hum Pathol. 1990 Jan;21(1):51–58. doi: 10.1016/0046-8177(90)90075-g. [DOI] [PubMed] [Google Scholar]
  2. Barnhill R. L., Roush G. C. Histopathologic spectrum of clinically atypical melanocytic nevi. II. Studies of nonfamilial melanoma. Arch Dermatol. 1990 Oct;126(10):1315–1318. [PubMed] [Google Scholar]
  3. Beral V., Evans S., Shaw H., Milton G. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol. 1983 Aug;109(2):165–172. doi: 10.1111/j.1365-2133.1983.tb07077.x. [DOI] [PubMed] [Google Scholar]
  4. Dubin N., Moseson M., Pasternack B. S. Epidemiology of malignant melanoma: pigmentary traits, ultraviolet radiation, and the identification of high-risk populations. Recent Results Cancer Res. 1986;102:56–75. doi: 10.1007/978-3-642-82641-2_5. [DOI] [PubMed] [Google Scholar]
  5. Elwood J. M., Williamson C., Stapleton P. J. Malignant melanoma in relation to moles, pigmentation, and exposure to fluorescent and other lighting sources. Br J Cancer. 1986 Jan;53(1):65–74. doi: 10.1038/bjc.1986.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Green A., Bain C., McLennan R., Siskind V. Risk factors for cutaneous melanoma in Queensland. Recent Results Cancer Res. 1986;102:76–97. doi: 10.1007/978-3-642-82641-2_6. [DOI] [PubMed] [Google Scholar]
  7. Green A., MacLennan R., Siskind V. Common acquired naevi and the risk of malignant melanoma. Int J Cancer. 1985 Mar 15;35(3):297–300. doi: 10.1002/ijc.2910350303. [DOI] [PubMed] [Google Scholar]
  8. Hicks N., Zack M., Caldwell G. G., McKinley T. W. Life-style factors among patients with melanoma. South Med J. 1985 Aug;78(8):903–908. doi: 10.1097/00007611-198508000-00003. [DOI] [PubMed] [Google Scholar]
  9. Holman C. D., Armstrong B. K. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst. 1984 Feb;72(2):257–266. [PubMed] [Google Scholar]
  10. Klepp O., Magnus K. Some environmental and bodily characteristics of melanoma patients. A case-control study. Int J Cancer. 1979 Apr 15;23(4):482–486. doi: 10.1002/ijc.2910230407. [DOI] [PubMed] [Google Scholar]
  11. MacKie R. M., English J., Aitchison T. C., Fitzsimons C. P., Wilson P. The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Br J Dermatol. 1985 Aug;113(2):167–174. doi: 10.1111/j.1365-2133.1985.tb02060.x. [DOI] [PubMed] [Google Scholar]
  12. MacKie R. M., Freudenberger T., Aitchison T. C. Personal risk-factor chart for cutaneous melanoma. Lancet. 1989 Aug 26;2(8661):487–490. doi: 10.1016/s0140-6736(89)92097-7. [DOI] [PubMed] [Google Scholar]
  13. Nordlund J. J., Kirkwood J., Forget B. M., Scheibner A., Albert D. M., Lerner E., Milton G. W. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res. 1985 Apr;45(4):1855–1861. [PubMed] [Google Scholar]
  14. Roush G. C. Abnormal nevi, excess total nevi, and melanoma: an epidemiologic perspective. Cancer Treat Res. 1988;43:85-100, 191-5. doi: 10.1007/978-1-4613-1751-7_6. [DOI] [PubMed] [Google Scholar]
  15. Roush G. C., Nordlund J. J., Forget B., Gruber S. B., Kirkwood J. M. Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma. Prev Med. 1988 May;17(3):273–279. doi: 10.1016/0091-7435(88)90003-5. [DOI] [PubMed] [Google Scholar]
  16. Swerdlow A. J., English J., MacKie R. M., O'Doherty C. J., Hunter J. A., Clark J., Hole D. J. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed) 1986 Jun 14;292(6535):1555–1559. doi: 10.1136/bmj.292.6535.1555. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES